Table 1. Clinical Data –

table provides demographic data about the cohort in total and then stratified by those patients who required massive transfusion and those who did not. Cited in the ‘Results’ section on page 5 of the manuscript.

	All Patients (n=190)		No Massive Transfusion (n=153)		Massive Transfusion (MTP) (n=37)
	N	Percent	N	Percent	N	Percent
Shock (SBP ≤ 90mmHg)	54	28.4%	30	32.1%	24	63.2%
Profound Shock (SBP ≤ 70mmHg)	25	13.2%	11	7.1%	14	36.8%
Lactate > 5 mg/dL	35	35.7%	21	26.9%	14	63.6%
Base Deficit > 8mEq/L	53	43.1%	32	32.3%	21	80.8%
Traumatic Brain Injury	24	12.6%	11	7.1%	13	34.2%
ICU-free Days < 14	42	22.1%	13	8.5%	29	78.4%
Ventilator-free Days <21	51	26.8%	20	13.1%	31	83.8%
Mortality	25	13.2%	6	3.9%	19	51.4%
Massive Transfusion Rate	37	19.5%
	Median	IQR	Median	IQR	Median	IQR
Age – years (n=190)	34	26–47	34	26–47	37	27–48
Time to ED -- minutes (n=190)	25	20.3–32	25	21–31.5	24	20–39
Injury Severity Score (ISS) (n=133)	22	10–34	14	9–29	38	29–43
New Injury Severity Score (NISS) (n=133)	27	14–43	17	9–29	50	38–60.8
Glasgow Coma Score (GCS) (n=190)	14.5	5.25–15	15	11.5–15	3	3–8
Temperature– C° (n=151)	36.45	36.3–36.8	36.55	36.3–36.8	36.3	35.7–36.9
Admission Calcium (n=168) units	8	7.6–8.5	8.1	7.7–8.5	7.7	7.2–8.4
Admission Hemoglobin (g/dL) (n=185)	13.9	12.5–15.3	14.1	13–15.4	12.3	9.9–14.0
Admission Platelets (1,000/ml) (n=184)	254.5	204–310	263	213–317	176.5	116.5–276
Admission International Normalized Ratio(INR) (n=180)	1.1	1.04–1.3	1.1	1–1.2	1.55	1.3–2.08
Admission Partial Thromboplastin Time (PTT) (n=180) units	27.75	24.7–33.1	26.85	23.8–29.8	42.9	32.6–74.0